Table 1.
Demographic and clinical characteristics of interview participants.
| Characteristic | Participants n=34 |
|---|---|
| Age [Mean (SD), range] | 56.9 (8.8), 39–71 |
| Race [n (%)] | |
| Caucasian | 31 (91.2) |
| African American | 1 (2.9) |
| Other | 2 (5.9) |
| Diagnosis of diabetes [n (%)] | 1 (2.9) |
| Chemotherapy setting [n (%)] | |
| Adjuvant | 25 (73.5) |
| Neoadjuvant | 9 (26.5) |
| Receipt 12 doses paclitaxel [n (%)]a | 22 (64.7) |
a
Four women decreased (range between doses 7 and 12) or delayed (range between doses 3 and 11) paclitaxel dose; nine women discontinued treatment before completing their 12 scheduled doses (range between doses 6 and 10).